Previous studies indicate that 3,4-methylenedioxy-methamphetamine (MDMA, ecstasy) can induce a heteromeric nicotinic acetylcholine receptor (nAChR, mainly of α4β2 subtype) up-regulation. In this study we treated male Sprague-Dawley rats twice-daily for 10 days with either saline or MDMA (7 mg/kg) and sacrificed them the day after to perform [ 125 I]Epibatidine binding autoradiograms on serial coronal slices. MDMA induced significant increases in nAChR density in the substantia nigra, ventral tegmental area, nucleus accumbens, olfactory tubercle, anterior caudate-putamen, somatosensory, motor, auditory and retrosplenial cortex, laterodorsal thalamus nuclei, amygdala, postsubiculum and pontine nuclei. These increases ranged from 3% (retrosplenial cortex) to 30 and 34% (amygdala and substantia nigra). No increased α4 subunit immunoreactivity was found in up-regulated areas compared with saline-treated rats, suggesting a post-translational mechanism as occurs with nicotine. The heteromeric nAChR up-regulation in certain areas could account, at least in part, for the reinforcing, sensitizing and psychiatric disorders observed after long-term consumption of MDMA.
Introduction
3,4-Methylenedioxy-methamphetamine (MDMA, ecstasy) is a psychostimulant and entactogen amphetamine derivative used illicitly for recreational purposes. Chronic MDMA can induce serotonergic and, to a lesser extent, dopaminergic neurotoxicity in rodents and primates (reviewed by Capela et al., 2009) . Such neurotoxicity can be a consequence of coordinated oxidative stress, metabolic compromise and inflammation (reviewed by Yamamoto and Raudensky, 2008) originating upon the interaction of MDMA with several targets such as monoamine transporters. Our research group reported a new target for MDMA involved in its neurotoxicity: the neuronal nicotinic acetylcholine receptors (nAChRs). MDMA behaves as a partial agonist on α7 nAChR, inducing prolonged Ca 2+ entry, which is related with calpain/ caspase 3 activation and cytotoxicity (Garcia-Rates et al., 2010) and as an antagonist on α4β2 nAChR. These effects could attenuate the reported protective effect of a full receptor activation (Mudo et al., 2007) . In animal and in in vitro models, α7 nAChR antagonists have protective effects against MDMA-induced neurotoxicity and cognitive impairment (see Pubill et al., 2011 for a review).
nAChRs are a family of ligand-gated cation channels widely distributed in the nervous system, whose subunit composition and signaling effects depend on subtype and localization (Albuquerque et al., 2009; Gotti et al., 2007) . They exert relevant effects on brain functions, involving fast synaptic transmission, cognitive enhancement, memory or reinforcement, and they are the main target of smoked nicotine. nAChRs are pentameric structures formed by the association of α and β subunits and can be either homomeric or heteromeric. Of these combinations, the most abundant are the heteromeric (α4) 2 (β2) 3 and homomeric α7 receptors. A particular feature of some nAChR subtypes is that, after chronic nicotine exposure, they undergo radioligand binding upregulation, changes in stoichiometry and increase in their functional state (functional up-regulation) (reviewed by Gaimarri et al., 2007) . Such up-regulation occurs at a post-translational level and several mechanisms have been proposed to explain it, including a chaperonelike maturation enhancing effect (Kuryatov et al., 2005; Lester et al., 2009; Sallette et al., 2005; Srinivasan et al., 2011) and stabilization of the high-affinity state of the receptors (Vallejo et al., 2005) . Moreover, nAChR up-regulation could enhance addiction to nicotine by increasing the pleasant effects of the drug (Govind et al., 2009) .
Besides its functional effects, we demonstrated that MDMA also induces in vitro up-regulation of both homomeric and heteromeric receptors on PC12 cells (Garcia-Rates et al., 2007) , through a mechanism that seemed to mimic that of nicotine. Moreover, in recent in vivo studies (Ciudad-Roberts et al., 2013; Pubill et al., 2013) 
